These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23621550)

  • 1. Cell-penetrating bisubstrate-based protein kinase C inhibitors.
    van Wandelen LT; van Ameijde J; Ismail-Ali AF; van Ufford HC; Vijftigschild LA; Beekman JM; Martin NI; Ruijtenbeek R; Liskamp RM
    ACS Chem Biol; 2013 Jul; 8(7):1479-87. PubMed ID: 23621550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
    van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
    ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
    Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
    Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exquisitely specific bisubstrate inhibitors of c-Src kinase.
    Brandvold KR; Santos SM; Breen ME; Lachacz EJ; Steffey ME; Soellner MB
    ACS Chem Biol; 2015 Jun; 10(6):1387-91. PubMed ID: 25793938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
    Lavogina D; Enkvist E; Uri A
    ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.
    Grant S; Tran P; Zhang Q; Zou A; Dinh D; Jensen J; Zhou S; Kang X; Zachwieja J; Lippincott J; Liu K; Johnson SL; Scales S; Yin C; Nukui S; Stoner C; Prasanna G; Lafontaine J; Wells P; Li H
    Eur J Pharmacol; 2010 Feb; 627(1-3):16-25. PubMed ID: 19850035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
    Ahn DR; Han KC; Kwon HS; Yang EG
    Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design.
    Hines AC; Parang K; Kohanski RA; Hubbard SR; Cole PA
    Bioorg Chem; 2005 Aug; 33(4):285-97. PubMed ID: 16023488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
    Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of peptide inhibitors for double-stranded RNA-dependent protein kinase PKR.
    Du MJ; Zhang HK; He AJ; Chang YS; Yang Y; Wang Y; Zhang CZ; Cao Y
    Biochemistry (Mosc); 2013 Nov; 78(11):1254-62. PubMed ID: 24460939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase structure and function analysis with chemical tools.
    Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of novel alkylated arginine derivatives suitable for click-cycloaddition chemistry and their incorporation into pseudosubstrate- and bisubstrate-based kinase inhibitors.
    van Ameijde J; Poot AJ; van Wandelen LT; Wammes AE; Ruijtenbeek R; Rijkers DT; Liskamp RM
    Org Biomol Chem; 2010 Apr; 8(7):1629-39. PubMed ID: 20237675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
    Cox KJ; Shomin CD; Ghosh I
    Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton.
    Räägel H; Lust M; Uri A; Pooga M
    FEBS J; 2008 Jul; 275(14):3608-24. PubMed ID: 18540886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the design of selective ATP-competitive kinase inhibitors].
    Deng XQ; Xiang ML; Jia R; Yang SY
    Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.